Furthermore, we proved that in low concentration, pristimerin inhibited the viability of glioma cells through AGO2, and suppressed expression PTPN1 via a canonical miRNA-mediated silencing mechanism, while in high concentration, pristimerin induced apoptosis. This evidence concerns the gene PTPN1 and central nervous system cancer.